Use of an anti-CD16 antibody for in vivo depletion of natural killer cells in rhesus macaques

Immunology

Volumn 124, Issue 2, 2008, Pages 215-222

  Choi, Elisa I ^a   Wang, Rijian ^a   Peterson, Lauren ^a   Letvin, Norman L ^a   Reimann, Keith A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Animal model; Calcein; Cytotoxicity; Immunophenotyping; Natural killer cell

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3G8; MONOCLONAL ANTIBODY CD16;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL LOSS; CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LYMPHOCYTE DEPLETION; MACACA; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FLUOROMETRY; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBSETS; MACACA MULATTA; RECEPTORS, IGG; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 43749118364     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02757.x     Document Type: Article

References (30)

1. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989 320 : 1731 5.
2. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbe Infect 2002 4 : 1545 58.
3. Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T. A glycolipid on the surface of mouse natural killer cells. Eur J Immunol 1980 10 : 175 80.
4. Lian RH, Kumar V. Murine natural killer cell progenitors and their requirements for development. Semin Immunol 2002 14 : 453 60.
5. + lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 1999 154 : 1923 32.
6. Jin X, Bauer DE, Tuttleton SE et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999 189 : 991 8.
7. Schmitz JE, Kuroda MJ, Santra S et al. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus. J Virol 2003 77 : 2165 73.
8. + T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003 197 : 1645 55.
9. Permar SR, Klumpp SA, Mansfield KG et al. Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis 2004 190 : 998 1005.
10. Edghill-Smith Y, Golding H, Manischewitz J et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against lethal monkeypox virus challenge. Nature Med 2005 11 : 740 7.
11. Carter DL, Shieh TM, Blosser RL, Chadwick KR, Margolick JB, Hildreth JE, Clements JE, Zink MC. CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry 1999 37 : 41 50.
12. Savary CA, Lotzova E, Jackson HJ, Jardine JH, Ang KK. Analysis of interleukin-2-activated killer cells of rhesus monkeys: striking resemblance to the human system. J Leukoc Biol 1993 54 : 307 13.
13. Webster RL, Johnson RP. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 2005 115 : 206 14.
14. Shields LE, Sieverkropp AJ, Potter J, Andrews RG. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro. Am J Primatol 2006 68 : 753 64.
15. γ receptor distribution and structure. Proc Natl Acad Sci USA 1982 79 : 3275 9.
16. Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 2000 74 : 1648 57.
17. Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 1994 172 : 227 39.
18. Neri S, Mariani E, Meneghetti A, Cattini L, Facchini A. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagn Lab Immunol 2001 8 : 1131 5.
19. Mavilio D, Benjamin J, Kim D et al. Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 2005 106 : 1718 25.
20. Ravetch JV, Perussia B. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 1989 170 : 481 97.
21. Rogers KA, Scinicariello F, Attanasio R. IgG Fc receptor III homologues in nonhuman primate species: genetic characterization and ligand interactions. J Immunol 2006 177 : 3848 56.
22. Rhesus Macaque Genome Sequencing and Analysis Consortium. Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007 316 : 222 34.
23. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003 19 : 71 82.
24. Cooper MA, Fehniger TA, Caligiuri MA. The biology of the human natural killer-cell subsets. Trends Immunol 2001 22 : 633 40.
25. Eger KA, Unutmaz D. The innate immune system and HIV pathogenesis. Curr HIV/AIDS Rep 2005 2 : 10 5.
26. Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 2005 5 : 835 43.
27. Alter G, Altfeld M. NK cell function in HIV-1 infection. Curr Mol Med 2006 6 : 621 9.
28. Wei Q, Stallworth JW, Vance PJ, Hoxie JA, Fultz PN. Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells. Clin Vaccine Immunol 2006 13 : 768 78.
29. + patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol 1998 161 : 6433 8.
30. Oliva A, Kinter AL, Vaccarezza M et al. Natural killer cells from human immunodeficiency virus (HIV) -infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 1998 102 : 223 31.